In corso

Preventing Parkinson’s Disease: Between Cellular Stress and Genetics

Condividi il progetto

Parkinson’s disease is one of the most common neurodegenerative disorders and is characterized by the gradual loss of dopaminergic neurons, which are essential for movement control. To date, there is no definitive cure, and the causes underlying disease development remain largely unknown. However, it is believed that a complex interplay between genetic and environmental factors contributes to its onset. In genetically predisposed individuals, external events such as infections, physical trauma, or severe emotional stress may trigger cellular mechanisms that initiate neurodegeneration.

In this project, researchers at the “Centro Dino Ferrari” aim to investigate the role of cellular stress response as a potential trigger in vulnerable individuals, with the goal of identifying new therapeutic targets and developing strategies for prevention or early intervention.

Methods and Technologies

The project integrates clinical data, multi-omics analyses, and patient-specific cellular models:

  • Collection of clinical data from a large cohort of Parkinson’s patients to identify triggering events prior to diagnosis.

  • Application of transcriptomics, proteomics, and lipidomics on both healthy individuals and genetically predisposed Parkinson’s patients.

  • Development of brain organoids from induced pluripotent stem cells (iPSCs) derived from patients and controls.

  • Testing therapies capable of modulating disease risk and progression in advanced cellular models.

  • Investigation of the “double-hit” mechanism to clarify interactions between genetic and environmental factors.

Expected Impact

  • Determination of risk factors: Clarification of the role of cellular stress response as a trigger in neurodegeneration.

  • Risk stratification: Development of predictive models to categorize genetically predisposed individuals according to risk.

  • Development of therapeutic approaches: Identification of new neuroprotective therapies tested in relevant, patient-specific cellular models.

Budget: €150,000

Contatti e approfondimenti

Contact: Dott. Alessio Di Fonzo
Mail: alessio.difonzo@policlinico.mi.it
Secretariat: elena.oriani@policlinico.mi.it

Sostieni anche tu questo progetto

Unisciti a noi e aiutaci a portare avanti la ricerca. La tua donazione può fare la differenza: indica il nome della patologia nel form dedicato per assicurarti che il tuo contributo venga destinato al progetto che hai a cuore.